Global Hydrocephalus Market, By Type (Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, and Ex-Vacuo Hydrocephalus), End Users (Hospitals, Clinics, Diagnostic Centers, and Academic Institutions and Research Organizations), Diagnostics & Treatment (Diagnostics and Treatment) – Industry Trend and Forecast to 2031.
Hydrocephalus Market Analysis and Size
The increasing incidences of neurological conditions among the population is driving the market growth. Also, the growing number of newborns globally is also expected to act as driver in the market growth. The poor reimbursement policies may restrain the market growth. The growing healthcare expenditure with rising strategic initiatives by the key market players is expected to act as an opportunity in the market growth. The high product recall scenario is expected to act as a challenge in the market growth.
Data Bridge Market Research analyzes that the global hydrocephalus market is expected to reach USD 2,592,720.77 thousand by 2031 from USD 1,587,759.20 thousand in 2023, growing with the CAGR of 6.5% in the forecast period of 2024 to 2031.
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
Type (Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, and Ex-Vacuo Hydrocephalus), End Users (Hospitals, Clinics, Diagnostic Centers, and Academic Institutions and Research Organizations), Diagnostics & Treatment (Diagnostics and Treatment)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Ireland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and Rest of Middle East and Africa
|
|
Market Players Covered
|
Integra LifeSciences, Aesculap, Inc. – a b. Braun company, G.SURGIWEAR LTD, Möller Medical GmbH, Anuncia Inc, CHRISTOPH MIETHKE GMBH & CO. KG, KARL STORZ SE & Co. KG, HpBio, Medtronic, Natus Medical Incorporated, Desu Medical, Bicakcilar, Spiegelberg GmbH & Co. KG, Sophysa, and KANEKA MEDIX CORP among others
|
Market Definition
Hydrocephalus is a condition in which excess Cerebrospinal Fluid (CSF) builds up within the fluid-containing cavities or ventricles of the brain. It can happen at any age, but it occurs more frequently among infants and adults 60 and over. Surgical treatment for hydrocephalus can restore and maintain normal cerebrospinal fluid levels in the brain. Several different therapies are often required to manage symptoms or functional impairments resulting from hydrocephalus. Various types of diagnosis and treatment devices are utilized in hydrocephalus market.
Global Hydrocephalus Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Increasing Incidence of Neurological Conditions
Neurological disorders impact up to a billion people around the world. There are various neurological conditions found which affect the different parts of brain. The most important neurological disorders are dementia, epilepsy, headache disorders, multiple sclerosis, and neuro infections, neurological disorders associated with malnutrition, pain associated with neurological disorders, Parkinson’s disease, stroke and traumatic brain injuries. Cases of neurological is rising globally in both pediatrics and geriatrics population. Hydrocephalus can be associated with various neurological conditions, such as tumors, infections, traumatic brain injuries, and congenital anomalies.
- Growing Number of New-Borns Affected by Hydrocephalus
Hydrocephalus is a medical condition characterized by an abnormal accumulation of Cerebrospinal Fluid (CSF) within the cavities of the brain, leading to increased intracranial pressure. It can be congenital or acquired and may affect individuals of all ages, including newborns. Rising number of pediatric hydrocephalic due to brain bleeds, brain tumors, head injury and infections as few days before and after birth are a time of risk for stroke in both mother and infant, probably related to activation of coagulation mechanisms in this critical period which is a major driving factor. Hydrocephalus can be congenital, meaning it occurs at birth or shortly afterward. The increasing global birth rate may lead to a higher number of cases of congenital hydrocephalus, driving the demand for medical interventions and treatments associated with the condition.
Opportunity
- Growing Support by Healthcare Organizations and Government Bodies
The support from healthcare organizations contributes to heightened awareness and education about hydrocephalus. These organizations often engage in public health campaigns, provide resources for patients and caregivers, and promote early detection and intervention. Such initiatives create a more informed patient population, leading to increased demand for hydrocephalus-related services and driving market growth. Government bodies' involvement can positively impact the hydrocephalus market through policy advocacy, funding allocation, and the development of supportive healthcare infrastructure. Policies that address reimbursement challenges, promote research and development, and improve patient access to care can enhance the overall market landscape.
Restraint/Challenge
- Poor Reimbursement Policies
Poor reimbursement policies may result in higher expenses for patients seeking treatment for hydrocephalus. This financial burden can discourage individuals from seeking timely medical care or opting for advanced treatment options, negatively impacting market growth. Advanced treatment options for hydrocephalus often involve expensive medical devices, surgical procedures, and ongoing healthcare services. If reimbursement policies do not adequately cover these costs, healthcare providers may be less inclined to invest in and offer the latest technologies, limiting patient access to innovative and effective treatments.
Recent Developments
- In January 2024, KANEKA MEDIX CORP has entered into an exclusive distribution agreement with an Israeli company for the distribution of Stent Retriever. It has helped in expanding their product line
- In July 2023, Luciole Medical AG has declared the acquisition of Spiegelberg GmbH & Co. KG, forming a prominent global developer and provider of brain monitoring solutions. Through the integration of their product suites, manufacturing capabilities, and distribution channels, the companies aim to enhance their strengths and create a unified entity
Global Hydrocephalus Market Scope
The global hydrocephalus market is segmented into three notable segments based on type, diagnostic & treatment, and end users. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Congenital Hydrocephalus
- Acquired Hydrocephalus
- Normal-Pressure Hydrocephalus
- Ex-Vacuo Hydrocephalus
On the basis of type, the market is segmented into congenital hydrocephalus, acquired hydrocephalus, normal-pressure hydrocephalus, and ex-vacuo hydrocephalus.
Diagnostics & Treatment
- Diagnostics
- Treatment
On the basis of diagnostic & treatment , the market is segmented into diagnostic and treatment.
End Users
- Hospitals
- Clinics
- Diagnostic Centers
- Academic Institutions and Research Organizations
On the basis of end users, the market is segmented into hospitals, clinics, diagnostic centers, and academic institutions and research organizations.
Global Hydrocephalus Market Regional Analysis/Insights
The global hydrocephalus market is segmented into three notable segments based on type, diagnostic & treatment, and end users.
The countries covered in the global hydrocephalus market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Ireland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and Rest of Middle East and Africa.
North America is expected to dominate the market as the region has been an early adopter of advanced technologies in healthcare. The region has a robust infrastructure for technological innovation and research, fostering the development and adoption of technological solutions. The U.S. is expected to dominate in the North America region due to its leadership stems from an advanced healthcare infrastructure, robust investment in R&D, a competitive landscape fostering innovation, and a significant number of clinical trials conducted across diverse therapeutic areas. Germany is expected to dominate in the Europe region due to its strong prominence on healthcare technology, sophisticated clinical research infrastructure, and a focus on precision medicine. The country boasts a robust pharmaceutical and biotechnology sector, fostering innovation and technological advancements in clinical assessments. Japan is expected to dominate in the Asia-Pacific region due to its growing healthcare sector, substantial investment in R&D, and the rapid digitization of its healthcare infrastructure.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter’s five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the region data.
Competitive Landscape and Global Hydrocephalus Market Share Analysis
The global hydrocephalus market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major market players operating in the global hydrocephalus market are Integra LifeSciences, Aesculap, Inc. – a b. Braun company, G.SURGIWEAR LTD, Möller Medical GmbH, Anuncia Inc, CHRISTOPH MIETHKE GMBH & CO. KG, KARL STORZ SE & Co. KG, HpBio, Medtronic, Natus Medical Incorporated, Desu Medical, Bicakcilar, Spiegelberg GmbH & Co. KG, Sophysa, and KANEKA MEDIX CORP among others.
SKU-